Bora Pharmaceuticals Co., LTD. (TPE: 6472)

Bora Pharmaceuticals Co., LTD. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6,229	3,053	3,281	910.75	669.99	452.68
Short-Term Investments	252.14	342.63	247.62	-	-	30
Trading Asset Securities	-	-	-	-	-	60.01
Cash & Short-Term Investments	6,481	3,396	3,529	910.75	669.99	542.69
Cash Growth	50.17%	-3.77%	287.48%	35.94%	23.46%	2.86%
Accounts Receivable	10,268	4,028	6,120	824.77	539.63	338.33
Other Receivables	951.48	82.61	286.38	33.23	186.77	7.74
Receivables	11,219	4,111	6,407	858.01	726.4	346.07
Inventory	5,437	2,272	1,991	928.64	1,112	297.11
Prepaid Expenses	569.78	186.69	242.47	63.07	51.33	11.95
Other Current Assets	112.6	637.76	71.58	31.87	67.01	48.44
Total Current Assets	23,819	10,603	12,241	2,792	2,627	1,246
Property, Plant & Equipment	11,923	7,493	7,300	4,067	4,158	2,035
Long-Term Investments	217.23	21.26	62.03	-	-	-
Goodwill	2,781	2,781	983.59	-	-	-
Other Intangible Assets	2,985	2,814	1,164	171.05	4.93	18.47
Long-Term Deferred Tax Assets	1,039	1,045	829.64	243.78	37.09	38.13
Other Long-Term Assets	809.86	294.85	181.01	98.65	177.22	44.92
Total Assets	43,574	25,052	22,761	7,372	7,004	3,383
Accounts Payable	884.3	380.45	454.74	235.81	219.06	62.91
Accrued Expenses	2,035	1,022	29.33	321.24	217.8	74.33
Short-Term Debt	2,346	767.51	2,161	645.48	1,218	225
Current Portion of Long-Term Debt	935.5	630.5	725.63	222.09	161.65	75.16
Current Portion of Leases	113.62	106.04	75.31	17.54	18.68	8.6
Current Income Taxes Payable	217.96	987.43	238.65	50.58	18.35	15.25
Current Unearned Revenue	252.88	224.6	85.69	20.47	4.11	4.99
Other Current Liabilities	6,339	4,110	6,725	327.91	428.77	90.81
Total Current Liabilities	13,123	8,229	10,496	1,841	2,286	557.05
Long-Term Debt	14,591	2,724	4,037	1,028	1,158	818.99
Long-Term Leases	757.37	763.33	596.88	305.97	325.37	290.17
Long-Term Unearned Revenue	-	-	4.18	-	-	-
Long-Term Deferred Tax Liabilities	926.45	701.74	742.85	609.77	202.01	60.93
Other Long-Term Liabilities	109.25	753.09	1,608	298.57	413.15	1.74
Total Liabilities	29,639	13,286	17,621	4,220	4,539	1,729
Common Stock	1,016	1,014	753.82	684.12	541.15	394.27
Additional Paid-In Capital	4,324	3,318	1,236	1,026	951.65	676.23
Retained Earnings	6,502	4,729	2,549	1,466	961.01	590.72
Treasury Stock	-46.72	-50.97	-53.09	-	-	-2.4
Comprehensive Income & Other	23.36	74.66	42.2	-23.26	10.95	-5.07
Total Common Equity	11,819	9,085	4,528	3,153	2,465	1,654
Minority Interest	2,116	2,681	612.13	-	-	-
Shareholders' Equity	13,935	11,766	5,140	3,153	2,465	1,654
Total Liabilities & Equity	43,574	25,052	22,761	7,372	7,004	3,383
Total Debt	18,744	4,991	7,596	2,219	2,881	1,418
Net Cash (Debt)	-12,263	-1,595	-4,067	-1,308	-2,211	-875.22
Net Cash Per Share	-115.62	-15.40	-41.20	-13.44	-22.91	-9.75
Filing Date Shares Outstanding	101.29	101.12	97.52	97.78	96.42	91.16
Total Common Shares Outstanding	101.29	101.12	97.52	97.78	96.42	91.16
Working Capital	10,696	2,374	1,745	951.22	340.48	689.21
Book Value Per Share	116.69	89.84	46.43	32.24	25.56	18.14
Tangible Book Value	6,053	3,489	2,381	2,981	2,460	1,635
Tangible Book Value Per Share	59.76	34.50	24.41	30.49	25.51	17.94
Land	3,903	3,424	3,397	1,984	2,021	889.81
Buildings	7,709	1,945	1,905	1,393	1,329	719.28
Machinery	4,873	2,506	2,390	859.79	838.14	392.11
Construction In Progress	439.02	115.84	76.72	11.73	-	-
Leasehold Improvements	264.72	251.81	205.29	-	8.1	8.1

Source: S&P Capital IQ. Standard template. Financial Sources.